天然活性成分抗乳腺癌的研究进展
Research Progress of Natural Active Ingredients against Breast Cancer
DOI: 10.12677/HJMCe.2024.121009, PDF,   
作者: 冉小娟：贵州中医药大学基础医学院，贵州 贵阳；余相地#：贵州省人民医院麻醉科，贵州 贵阳
关键词: 乳腺癌；天然活性成分；研究进展；Breast Cancer； Natural Active Ingredients； Research Progress
摘要: 放眼全球，乳腺癌(Breast Cancer, BC)是最常见和反复发作的疾病之一，也是女性死亡的第二大原因。乳腺癌对女性不仅身体上造成伤害，还给精神和经济上带来沉重的负担。尽管有预防、诊断和治疗选择，如放疗和化疗，但发病率每年都在增加。目前应用的化学疗法仍然存在问题，如癌细胞的异质性、对正常组织的严重毒性、快速产生耐药性和疾病复发，以及癌症干细胞的聚集和无法阻止病情进展至侵入性/转移性阶段。因此，需要开发针对不同亚型乳腺癌的新型治疗药物。在可用于治疗乳腺癌的药物中，天然产物如植物衍生化合物显示出抗乳腺癌特性。这些物质属于不同的化学类别，如黄酮类、皂苷类、萜类和生物碱类等。它们通过不同的机制对乳腺癌细胞进行体内外的细胞毒性活性，包括抑制外源性和内源性凋亡途径、阻碍细胞周期和激活自噬。此外，它们还表现出抗血管生成和抑制侵袭的作用。本综述的目的是整理具有抗肿瘤活性的天然生物活性化合物对乳腺癌的作用机制，为天然活性成分抗乳腺癌的临床应用提供科学依据。
Abstract: Globally, breast cancer (BC) is one of the most common and recurrent diseases and the second leading cause of death among women. Breast cancer not only takes a physical toll on women, but also places a heavy emotional and financial burden. Despite the availability of preventive, diagnostic and therapeutic options, such as radiotherapy and chemotherapy, the incidence is increasing every year. Currently applied chemotherapies still have problems such as heterogeneity of cancer cells, severe toxicity to normal tissues, rapid development of drug resistance and disease recurrence, as well as aggregation of cancer stem cells and inability to prevent progression to invasive/metastatic stages. Therefore, there is a need to develop novel therapeutic agents that target different subtypes of breast cancer. Among the drugs available for the treatment of breast cancer, natural products such as plant-derived compounds show anti-breast cancer properties. These substances belong to different chemical classes such as flavonoids, saponins, terpenoids and alkaloids. They exert cytotoxic activity against breast cancer cells ex vivo and in vivo through different mechanisms, including inhibition of exogenous and endogenous apoptotic pathways, obstruction of the cell cycle and activation of autophagy. In addition, they exhibit anti-angiogenic and inhibitory effects on invasion. The aim of this review is to organize the mechanisms of action of natural bioactive compounds with antitumor activity against breast cancer and to provide a scientific basis for the clinical application of natural active ingredients against breast cancer.
文章引用：冉小娟, 余相地. 天然活性成分抗乳腺癌的研究进展[J]. 药物化学, 2024, 12(1): 68-76. https://doi.org/10.12677/HJMCe.2024.121009

参考文献

[1] Li, P.C., Zhu, Y.F., Cao, W.M., et al. (2024) ER-Positive and BRCA2-Mutated Breast Cancer: A Literature Review. European Journal of Medical Research, 29, Article No. 30. [Google Scholar] [CrossRef] [PubMed]
[2] Zhong, X.D., Chen, L.J., Xu, X.Y., et al. (2022) Berberine as a Potential Agent for Breast Cancer Therapy. Frontiers in Oncology, 12, Article 993775. [Google Scholar] [CrossRef] [PubMed]
[3] El-Baba, C., Baassiri, A., Kiriako, G., et al. (2021) Terpenoids’ An-ti-Cancer Effects: Focus on Autophagy. Apoptosis: An International Journal on Programmed Cell Death, 26, 491-511. [Google Scholar] [CrossRef] [PubMed]
[4] Rufino, A.T., Costa, V.M., Carvalho, F., et al. (2021) Flavo-noids as Antiobesity Agents: A Review. Medicinal Research Reviews, 41, 556-585. [Google Scholar] [CrossRef] [PubMed]
[5] Ribeiro, D., Freitas, M., Lima, J.L, et al. (2015) Proinflammatory Path-ways: The Modulation by Flavonoids. Medicinal Research Reviews, 35, 877-936. [Google Scholar] [CrossRef] [PubMed]
[6] Almeida Rezende, B., Pereira, A.C., Cortes, S.F., et al. (2016) Vascular Effects of Flavonoids. Current Medicinal Chemistry, 23, 87-102. [Google Scholar] [CrossRef] [PubMed]
[7] Mira, A., Alkhiary, W. and Shimizu, K. (2017) An-tiplatelet and Anticoagulant Activities of Angelica Shikokiana Extract and Its Isolated Compounds. Clinical and Applied Thrombosis/Hemostasis, 23, 91-99. [Google Scholar] [CrossRef] [PubMed]
[8] Proença, C., Freitas, M., Ribeiro, D., et al. (2017) α-Glucosidase Inhibition by Flavonoids: An in Vitro and in Silico Structure-Activity Relationship Study. Journal of Enzyme Inhibition and Medicinal Chemistry, 32, 1216-1228. [Google Scholar] [CrossRef] [PubMed]
[9] Frandsen, J.R. and Narayanasamy, P. (2018) Neuroprotec-tion through Flavonoid: Enhancement of the Glyoxalase Pathway. Redox Biology, 14, 465-473. [Google Scholar] [CrossRef] [PubMed]
[10] Khan, H., Perviz, S., Sureda, A., et al. (2018) Current Standing of Plant Derived Flavonoids as an Antidepressant. Food and Chemical Toxicology, 119, 176-188. [Google Scholar] [CrossRef] [PubMed]
[11] Kopustinskiene, D.M., Jakstas, V., Savickas, A., et al. (2020) Fla-vonoids as Anticancer Agents. Nutrients, 12, Article 457. [Google Scholar] [CrossRef] [PubMed]
[12] Zhang, Q., Le-nardo, M.J. and Baltimore, D. (2017) 30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology. Cell, 168, 37-57. [Google Scholar] [CrossRef] [PubMed]
[13] Sen, R. and Baltimore, D. (1986) Multiple Nuclear Factors Interact with the Immunoglobulin Enhancer Sequences. Cell, 46, 705-716. [Google Scholar] [CrossRef] [PubMed]
[14] Song, L., Chen, X., Mi, L., et al. (2020) Icariin-Induced Inhi-bition of SIRT6/NF-κB Triggers Redox Mediated Apoptosis and Enhances Anti-Tumor Immunity in Triple-Negative Breast Cancer. Cancer Science, 111, 4242-4256. [Google Scholar] [CrossRef] [PubMed]
[15] Sharma, V.R., Gupta, G.K., Sharma, A.K., et al. (2017) PI3K/Akt/MTOR Intracellular Pathway and Breast Cancer: Factors, Mechanism and Regulation. Current Pharmaceutical Design, 23, 1633-1638. [Google Scholar] [CrossRef] [PubMed]
[16] Hussain, Y., Khan, H., Alam, W., et al. (2022) Fla-vonoids Targeting the MTOR Signaling Cascades in Cancer: A Potential Crosstalk in Anti-Breast Cancer Therapy. Oxi-dative Medicine and Cellular Longevity, 2022, Article ID: 4831833. [Google Scholar] [CrossRef] [PubMed]
[17] Chen, L., Zeng, T., Pan, X., et al. (2019) Identifying Methylation Pat-tern and Genes Associated with Breast Cancer Subtypes. International Journal of Molecular Sciences, 20, Article 4269. [Google Scholar] [CrossRef] [PubMed]
[18] Yang, G.J., Zhong, H.J., Ko, C.N., et al. (2018) Identification of a Rhodium(III) Complex as a Wee1 Inhibitor against TP53-Mutated Triple-Negative Breast Cancer Cells. Chemical Com-munications (Cambridge, England), 54, 2463-2466. [Google Scholar] [CrossRef] 
[19] Li, X., Zhou, N., Wang, J., et al. (2018) Quercetin Suppresses Breast Cancer Stem Cells (CD44+/CD24−) by Inhibiting the PI3K/Akt/MTOR-Signaling Pathway. Life Sciences, 196, 56-62. [Google Scholar] [CrossRef] [PubMed]
[20] Syed, D.N., Adhami, V.M., Khan, M.I., et al. (2013) Inhibition of Akt/MTOR Signaling by the Dietary Flavonoid Fisetin. Anti-Cancer Agents in Medicinal Chemistry, 13, 995-1001. [Google Scholar] [CrossRef] [PubMed]
[21] Zhou, R., Chen, H., Chen, J., et al. (2018) Extract from Astragalus membranaceus Inhibit Breast Cancer Cells Proliferation via PI3K/AKT/MTOR Signaling Pathway. BMC Complementary and Alternative Medicine, 18, Article No. 83. [Google Scholar] [CrossRef] [PubMed]
[22] Rivera Rivera, A., Castillo-Pichardo, L., Gerena, Y., et al. (2016) Anti-Breast Cancer Potential of Quercetin via the Akt/AMPK/Mammalian Target of Rapamycin (MTOR) Signaling Cas-cade. PLOS ONE, 11, e0157251. [Google Scholar] [CrossRef] [PubMed]
[23] Won, Y.S. and Seo, K.I. (2020) Lupiwighteone Induces Caspa-se-Dependent and -Independent Apoptosis on Human Breast Cancer Cells via Inhibiting PI3K/Akt/MTOR Pathway. Food and Chemical Toxicology, 135, Article 110863. [Google Scholar] [CrossRef] [PubMed]
[24] Bonizzi, A., Truffi, M., Sevieri, M., et al. (2019) Everolimus Nanoformulation in Biological Nanoparticles Increases Drug Responsiveness in Resistant and Low-Responsive Breast Cancer Cell Lines. Pharmaceutics, 11, Article 384. [Google Scholar] [CrossRef] [PubMed]
[25] Fleming, G.F., Ma, C.X., Huo, D., et al. (2012) Phase II Trial of Temsirolimus in Patients with Metastatic Breast Cancer. Breast Cancer Research and Treatment, 136, 355-363. [Google Scholar] [CrossRef] [PubMed]
[26] Bachelot, T., Bourgier, C., Cropet, C., et al. (2012) Randomized Phase II Trial of Everolimus in Combination with Tamoxifen in Patients with Hormone Receptor-Positive, Human Epi-dermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer with Prior Exposure to Aromatase Inhibitors: A GINECO Study. Journal of Clinical Oncology, 30, 2718-2724. [Google Scholar] [CrossRef] 
[27] AndrE, F., O’Regan, R., Ozguroglu, M., et al. (2014) Everolimus for Women with Trastuzumab-Resistant, HER2-Positive, Advanced Breast Cancer (BOLERO-3): A Randomised, Dou-ble-Blind, Placebo-Controlled Phase 3 Trial. The Lancet. Oncology, 15, 580-591. [Google Scholar] [CrossRef] 
[28] Seiler, M., Ray-Coquard, I., Melichar, B., et al. (2015) Oral Ridaforolimus plus Trastuzumab for Patients with HER2+ Trastuzumab-Refractory Metastatic Breast Cancer. Clinical Breast Cancer, 15, 60-65. [Google Scholar] [CrossRef] [PubMed]
[29] Hurvitz, S.A., Dalenc, F., Campone, M., et al. (2013) A Phase 2 Study of Everolimus Combined with Trastuzumab and Paclitaxel in Patients with HER2-Overexpressing Advanced Breast Cancer That Progressed During Prior Trastuzumab and Taxane Therapy. Breast Cancer Research and Treatment, 141, 437-446. [Google Scholar] [CrossRef] [PubMed]
[30] Upadhyay, S., Jeena, G.S., Shikha, et al. (2018) Recent Advances in Steroidal Saponins Biosynthesis and in Vitro Production. Planta, 248, 519-544. [Google Scholar] [CrossRef] [PubMed]
[31] Yendo, A.C., De Costa, F., Gosmann, G., et al. (2010) Produc-tion of Plant Bioactive Triterpenoid Saponins: Elicitation Strategies and Target Genes to Improve Yields. Molecular Biotechnology, 46, 94-104. [Google Scholar] [CrossRef] [PubMed]
[32] Zhao, Y.Z., Zhang, Y.Y., Han, H., et al. (2018) Advances in the Antitumor Activities and Mechanisms of Action of Steroidal Saponins. Chinese Journal of Natural Medicines, 16, 732-748. [Google Scholar] [CrossRef] 
[33] Man, S., Gao, W., Zhang, Y., et al. (2010) Chemical Study and Medical Application of Saponins as Anti-Cancer Agents. Fitoterapia, 81, 703-714. [Google Scholar] [CrossRef] [PubMed]
[34] Zhang, S., He, Y., Tong, Q., et al. (2013) Deltonin Induces Apoptosis in MDA-MB-231 Human Breast Cancer Cells via Reactive Oxygen Species-Mediated Mitochondrial Dys-function and ERK/AKT Signaling Pathways. Molecular Medicine Reports, 7, 1038-1044. [Google Scholar] [CrossRef] [PubMed]
[35] Fang, J.Y. and Richardson, B.C. (2005) The MAPK Signalling Path-ways and Colorectal Cancer. The Lancet. Oncology, 6, 322-327. [Google Scholar] [CrossRef] 
[36] Viglietto, G., Motti, M.L., Bruni, P., et al. (2002) Cytoplas-mic Relocalization and Inhibition of the Cyclin-Dependent Kinase Inhibitor P27Kip1 by PKB/Akt-Mediated Phosphoryla-tion in Breast Cancer. Nature Medicine, 8, 1136-1144. [Google Scholar] [CrossRef] [PubMed]
[37] Si, Y., Ji, X., Cao, X., et al. (2017) Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1. Cancer Research, 77, 4868-4880. [Google Scholar] [CrossRef] 
[38] Calses, P.C., Crawford, J.J., Lill, J.R., et al. (2019) Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic Opportunities. Trends in Cancer, 5, 297-307. [Google Scholar] [CrossRef] [PubMed]
[39] Cao, J. and Huang, W. (2017) Two Faces of Hippo: Activate Or Suppress the Hippo Pathway in Cancer. Anti-Cancer Drugs, 28, 1079-1085. [Google Scholar] [CrossRef] 
[40] Zheng, Y. and Pan, D. (2019) The Hippo Signaling Path-way in Development and Disease. Developmental Cell, 50, 264-282. [Google Scholar] [CrossRef] [PubMed]
[41] Xiang, Y.C., Peng, P., Liu, X.W., et al. (2022) Paris Saponin VII, a Hippo Pathway Activator, Induces Autophagy and Exhibits Therapeutic Potential against Human Breast Cancer Cells. Acta Pharmacologica Sinica, 43, 1568-1580. [Google Scholar] [CrossRef] [PubMed]
[42] Wang, D., Sha, L., Xu, C., et al. (2022) Natural Saponin and Cholesterol Assembled Nanostructures as the Promising Delivery Method for Saponin. Colloids and Surfaces B, Bioin-terfaces, 214, Article 112448. [Google Scholar] [CrossRef] [PubMed]
[43] Tan, H., Zhang, M., Wu, X., et al. (2021) New An-ti-Proliferative Triterpenes from Hydrolyzate of Total Gynostemma pentaphyllum Saponins Induces Cell Cycle Arrest and Apoptosis in Human Breast Cancer Cells. Phytochemistry Letters, 46, 166-171. [Google Scholar] [CrossRef] 
[44] Yin, L., Fan, Z., Liu, P., et al. (2021) Anemoside A3 Activates TLR4-Dependent M1-Phenotype Macrophage Polarization to Represses Breast Tumor Growth and Angiogenesis. Toxi-cology and Applied Pharmacology, 432, Article 115755. [Google Scholar] [CrossRef] [PubMed]
[45] Xia, L., Liu, X., Mao, W., et al. (2023) Panax notoginseng Saponins Normalises Tumour Blood Vessels by Inhibiting EphA2 Gene Expression to Modulate the Tumour Microenvironment of Breast Cancer. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, 114, Article 154787. [Google Scholar] [CrossRef] [PubMed]
[46] Wang, P., Cui, J., Du, X., et al. (2014) Panax notoginseng Saponins (PNS) Inhibits Breast Cancer Metastasis. Journal of Ethnopharmacology, 154, 663-671. [Google Scholar] [CrossRef] [PubMed]
[47] Li, Y., Sun, Y., Tang, T., et al. (2019) Paris Saponin VII Reverses Chemoresistance in Breast MCF-7/ADR Cells. Journal of Ethnopharmacology, 232, 47-54. [Google Scholar] [CrossRef] [PubMed]
[48] Ziegler, J. and Facchini, P.J. (2008) Alkaloid Biosynthesis: Metabo-lism and Trafficking. Annual Review of Plant Biology, 59, 735-769. [Google Scholar] [CrossRef] [PubMed]
[49] Chipiti, T., Viljoen, A.M., Cordero-Maldonado, M.L., et al. (2021) Anti-Seizure Activity of African Medicinal Plants: The Identification of Bioactive Alkaloids from the Stem Bark of Rauvolfia Caffra Using an in Vivo Zebrafish Model. Journal of Ethnopharmacology, 279, Article 114282. [Google Scholar] [CrossRef] [PubMed]
[50] Takayama, H., Ishikawa, H., Kurihara, M., et al. (2002) Studies on the Synthesis and Opioid Agonistic Activities of Mitragynine-Related Indole Alkaloids: Discovery of Opioid Agonists Structurally Different from Other Opioid Ligands. Journal of Medicinal Chemistry, 45, 1949-1956. [Google Scholar] [CrossRef] [PubMed]
[51] Nair, J.J. and Van Staden, J. (2023) Antiviral Alkaloid Principles of the Plant Family Amaryllidaceae. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, 108, Arti-cle 154480. [Google Scholar] [CrossRef] [PubMed]
[52] Chen, D., Ma, Y., Guo, Z., et al. (2020) Two Natural Alka-loids Synergistically Induce Apoptosis in Breast Cancer Cells by Inhibiting STAT3 Activation. Molecules (Basel, Swit-zerland), 25, Article 216. [Google Scholar] [CrossRef] [PubMed]
[53] Grabarska, A., Wróblewska-Łuczka, P., Kukula-Koch, W., et al. (2021) Palmatine, a Bioactive Protoberberine Alkaloid Isolated from Berberis Cretica, Inhibits the Growth of Human Es-trogen Receptor-Positive Breast Cancer Cells and Acts Synergistically and Additively with Doxorubicin. Molecules (Basel, Switzerland), 26, Article 6253. [Google Scholar] [CrossRef] [PubMed]
[54] Liu, X.Y., Wang, Y.M., Zhang, X.Y., et al. (2022) Alkaloid De-rivative (Z)-3β-Ethylamino-Pregn-17(20)-En Inhibits Triple-Negative Breast Cancer Metastasis and Angiogenesis by Targeting HSP90α. Molecules (Basel, Switzerland), 27, Article 7132. [Google Scholar] [CrossRef] [PubMed]
[55] Zhao, W., Zheng, X.D., Tang, P.Y, Z., et al. (2023) Advances of Antitumor Drug Discovery in Traditional Chinese Medicine and Natural Active Products by Using Multi-Active Com-ponents Combination. Medicinal Research Reviews, 43, 1778-1808. [Google Scholar] [CrossRef] [PubMed]
[56] Thomas, C.J., Rahier, N.J. and Hecht, S.M. (2004) Camptothecin: Current Perspectives. Bioorganic & Medicinal Chemistry, 12, 1585-1604. [Google Scholar] [CrossRef] [PubMed]
[57] Wang, Y.L., Wu, W., Su, Y.N., et al. (2020) Buxus Alkaloid Compound Destabilizes Mutant P53 through Inhibition of the HSF1 Chaperone Axis. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, 68, Article 153187. [Google Scholar] [CrossRef] [PubMed]
[58] Huang, M. and Xin, W. (2018) Matrine Inhibiting Pancreatic Cells Epithelial-Mesenchymal Transition and Invasion through ROS/NF-κB/MMPs Pathway. Life Sciences, 192, 55-61. [Google Scholar] [CrossRef] [PubMed]
[59] Luo, D., Dai, X., Tian, H., et al. (2023) Sophflarine A, a Novel Matrine-Derived Alkaloid from Sophora flavescens with Therapeutic Potential for Non-Small Cell Lung Cancer through ROS-Mediated Pyroptosis and Autophagy. Phytomedicine, 116, Article 154909. [Google Scholar] [CrossRef] [PubMed]
[60] Abe, A. and Kokuba, H. (2013) Harmol Induces Autophagy and Subsequent Apoptosis in U251MG Human Glioma Cells through the Downregulation of Survivin. Oncology Re-ports, 29, 1333-1342. [Google Scholar] [CrossRef] [PubMed]
[61] Wang, X.D., Li, C.Y., Jiang, M.M., et al. (2016) Induction of Apoptosis in Human Leukemia Cells through an Intrinsic Pathway by Cathachunine, a Unique Alkaloid Isolated from Catharanthus roseus. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, 23, 641-653. [Google Scholar] [CrossRef] [PubMed]
[62] Withers, S.T. and Keasling, J.D. (2007) Biosynthesis and Engineering of Isoprenoid Small Molecules. Applied Microbiology and Biotechnology, 73, 980-990. [Google Scholar] [CrossRef] [PubMed]
[63] Kim, S.J. and Kim, A.K. (2015) Anti-Breast Cancer Activity of Fine Black Ginseng (Panax ginseng Meyer) and Ginsenoside Rg5. Journal of Ginseng Research, 39, 125-134. [Google Scholar] [CrossRef] [PubMed]
[64] Lan, T., Wang, L., Xu, Q., et al. (2013) Growth Inhibitory Effect of Cucurbitacin E on Breast Cancer Cells. International Journal of Clinical and Experimental Pathology, 6, 1799-1805.
[65] Cho, M., So, I., Chun, J.N., et al. (2016) The Antitumor Effects of Geraniol: Modulation of Cancer Hallmark Pathways (Review). International Journal of Oncology, 48, 1772-1782. [Google Scholar] [CrossRef] [PubMed]
[66] Lu, Q., Chen, W., Ji, Y., et al. (2022) Ursolic Acid Enhances Cytotoxi-city of Doxorubicin-Resistant Triple-Negative Breast Cancer Cells via ZEB1-AS1/miR-186-5p/ABCC1 Axis. Cancer Bi-otherapy & Radiopharmaceuticals, 37, 673-683. [Google Scholar] [CrossRef] [PubMed]
[67] Eelen, G., Treps, L., Li, X., et al. (2020) Basic and Therapeutic Aspects of Angiogenesis Updated. Circulation Research, 127, 310-329. [Google Scholar] [CrossRef] 
[68] Teleanu, R.I., Chircov, C., Grumezescu, A.M., et al. (2019) Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment. Journal of Clinical Medicine, 9, Arti-cle 84. [Google Scholar] [CrossRef] [PubMed]
[69] Ribatti, D., Nico, B., Ruggieri, S., et al. (2016) Angiogenesis and Antiangiogenesis in Triple-Negative Breast Cancer. Translational Oncology, 9, 453-457. [Google Scholar] [CrossRef] [PubMed]
[70] Rao, Q., Yu, H., Li, R., et al. (2023) Dihydroartemisinin Inhibits Angiogenesis in Breast Cancer via Regulating VEGF and MMP-2/-9. Fundamental & Clinical Pharmacology, 509, 321-233. [Google Scholar] [CrossRef] [PubMed]
[71] Gonzalez-Angulo, A.M., Morales-Vasquez, F. and Hortobagyi, G.N. (2007) Overview of Resistance to Systemic Therapy in Patients with Breast Cancer. In: Yu, D. and Hung, M.C., Eds., Advances in Experimental Medicine and Biology, Vol. 608, Springer, New York, 1-22. [Google Scholar] [CrossRef] [PubMed]
[72] Zhai, Z., Qu, X., Li, H., et al. (2015) Inhibition of MDA-MB-231 Breast Cancer Cell Migration and Invasion Activity by Andrographolide via Suppression of Nuclear Factor-κB-Dependent Matrix Metalloproteinase-9 Expression. Molecular Medicine Reports, 11, 1139-1145. [Google Scholar] [CrossRef] [PubMed]
[73] Rabi, T. and Bishayee, A. (2009) Terpenoids and Breast Cancer Chemoprevention. Breast Cancer Research and Treatment, 115, 223-239. [Google Scholar] [CrossRef] [PubMed]
[74] Giovannucci, E. (1999) Tomatoes, Tomato-Based Products, Ly-copene, and Cancer: Review of the Epidemiologic Literature. Journal of the National Cancer Institute, 91, 317-331. [Google Scholar] [CrossRef] [PubMed]
[75] Giovannucci, E., Rimm, E.B., Liu, Y., et al. (2002) A Prospective Study of Tomato Products, Lycopene, and Prostate Cancer Risk. Journal of the National Cancer Institute, 94, 391-398. [Google Scholar] [CrossRef] [PubMed]
[76] Trejo-Solis, C., Pedraza-Chaverri, J., Torres-Ramos, M., et al. (2013) Multiple Molecular and Cellular Mechanisms of Action of Lycopene in Cancer Inhibition. Evidence-Based Complemen-tary and Alternative Medicine, 2013, Article ID: 705121. [Google Scholar] [CrossRef] [PubMed]
[77] Luo, H., Vong, C.T., Chen, H., et al. (2019) Naturally Occurring Anti-Cancer Compounds: Shining from Chinese Herbal Medicine. Chinese Medicine, 14, Article No. 48. [Google Scholar] [CrossRef] [PubMed]